- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.12. | Cogstate Revenue Guidance Falls Short of Expectations | 3 | Finance News Network | ||
| 10.12. | Health Check: Cogstate suffers a nasty share price head knock, but its future 'has never looked brighter' | 1 | Stockhead | ||
| 10.12. | Why Cogstate, European Lithium, GQG Partners, and Lindian Resources shares are falling today | 102 | The Motley Fool Australia | ||
| COGSTATE Aktie jetzt für 0€ handeln | |||||
| 09.12. | COGSTATE LTD: Cogstate Business Update | - | ASX | ||
| 05.12. | COGSTATE LTD: S&P DJI Announces December 2025 Quarterly Rebalance | - | ASX | ||
| 24.11. | COGSTATE LTD: Cogstate Investor Presentation | - | ASX | ||
| 11.11. | COGSTATE LTD: Notification of buy-back - CGS | 1 | ASX | ||
| 10.11. | COGSTATE LTD: Cogstate Share Buyback | - | ASX | ||
| 10.11. | COGSTATE LTD: Update - Notification of buy-back - CGS | - | ASX | ||
| 06.11. | COGSTATE LTD: Cogstate Shareholder Day Summary | - | ASX | ||
| 03.11. | COGSTATE LTD: Ceasing to be a substantial holder - Anacacia Pty Limited | - | ASX | ||
| 03.11. | COGSTATE LTD: Change of Director's Interest Notice - BOC | - | ASX | ||
| 03.11. | COGSTATE LTD: Notification regarding unquoted securities - CGS | 1 | ASX | ||
| 24.10. | Trigg Minerals, NRW Holdings, Cogstate: All the biggest ASX director trades from the last week | 8 | The Market Herald Australia | ||
| 20.10. | COGSTATE LTD: Change of Director's Interest Notice - BOC | - | ASX | ||
| 20.10. | COGSTATE LTD: Application for quotation of securities - CGS | - | ASX | ||
| 17.10. | COGSTATE LTD: Exercise of options and sale of shares by CEO | - | ASX | ||
| 16.10. | COGSTATE LTD: Results of 2025 Annual General Meeting | - | ASX | ||
| 15.10. | COGSTATE LTD: 2025 Annual General Meeting Address to Shareholders | - | ASX | ||
| 15.10. | COGSTATE LTD: Business Update | - | ASX |
1 2 3 Weiter >>
50 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 44,640 | +0,97 % | Moody's vergibt Investmentgrade-Rating "A3" an Siemens Healthineers | DJ Moody's vergibt Investmentgrade-Rating "A3" an Siemens Healthineers
DOW JONES--Moody's hat Siemens Healthineers die Bonitätsbewertung A3 gegeben, was als sichere Anlage gilt. Der Ausblick ist... ► Artikel lesen | |
| FRESENIUS | 47,780 | +0,74 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius mit einem Kursziel von 53,60 Euro auf "Overweight" belassen. Die Veranstaltung mit dem Biopharma-Management der Bad... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,300 | +0,30 % | Fresenius Medical Care ernennt neuen Chief Medical Officer | DJ Fresenius Medical Care ernennt neuen Chief Medical Officer
DOW JONES--Fresenius Medical Care bekommt einen neuen Chief Medical Officer. Wie der Dialysespezialist mitteilte, hat er Charles Hugh-Jones... ► Artikel lesen | |
| HEARTBEAM | 3,020 | -12,46 % | Heartbeam stock is a buy, this analyst says | ||
| CARL ZEISS MEDITEC | 40,000 | +0,15 % | UBS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 53 Euro auf "Neutral" belassen. Die Suche nach einem neuen Chef laufe, aber werde... ► Artikel lesen | |
| GERRESHEIMER | 26,880 | -0,67 % | UBS stuft GERRESHEIMER AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Gerresheimer nach einem "Report" eines Leerverkäufers mit einem Kursziel von 29 Euro auf "Neutral" belassen. Er habe bereits... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,840 | -1,66 % | BrightSpring upgraded at KeyBanc on specialty pharmacy and EBITDA prospects | ||
| PROGYNY | 25,940 | -0,35 % | Progyny, Inc. - 8-K, Current Report | ||
| ALIGNMENT HEALTHCARE | 20,520 | +2,45 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 34,440 | -3,39 % | UBS stuft Procept BioRobotics mit "Buy" ein - Wachstum bei Systemauslastung als Treiber | ||
| CASTLE BIOSCIENCES | 39,770 | +1,82 % | Castle Biosciences, Inc.: Systematic Review and Meta-Analysis Confirms TissueCypher Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer | FRIENDSWOOD, Texas, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication... ► Artikel lesen | |
| ECKERT & ZIEGLER | 14,650 | -1,08 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| CLEARPOINT NEURO | 14,040 | +1,45 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Completes Acquisition of IRRAS | Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire... ► Artikel lesen | |
| BETA BIONICS | 29,500 | -0,44 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| NUTEX HEALTH | 160,32 | -6,60 % | Nutex Health, Inc.: Nutex Health Responds To Short Seller Report | HOUSTON, Nov. 26, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), is aware of a short seller report issued on November... ► Artikel lesen |
Das Unternehmen COGSTATE LTD kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu COGSTATE LTD finden Sie auf Wallstreet Online.